The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date
Crossref DOI link: https://doi.org/10.1007/s40265-016-0565-4
Published Online: 2016-04-06
Published Print: 2016-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Seiler, Till
Hutter, Grit
Dreyling, Martin
Text and Data Mining valid from 2016-04-01